Trinity Biotech PLC (NASDAQ:TRIB)
| 16.88 Data as of May 20 |  +0.33 / +1.99%Today’s Change | 10.89 Today|||52-Week Range 19.00 | +17.06% Year-to-Date |
Latest TRIB News | Press Releases
No recent news for Trinity Biotech PLC.
Today’s Trading
| Previous close | 16.55 |
| Today’s open | 16.50 |
| Day’s range | -- - -- |
| Volume | 50,732 |
| Average volume (3 months) | 77,914 |
| Market cap | $368.8M |
| Dividend yield | 0.89% |
Data as of 3:59pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | +10.09% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +4.88% |
| P/E ratio | 93.8 |
| Price/Sales | 3.77 |
| Price/Book | 2.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALRPRBAlere Inc | 0.00 | 0.00% |
| AMAGAMAG Pharmaceuticals... | -0.44 | -1.73% |
| BDSIBioDelivery Sciences... | -0.21 | -4.43% |
| --Medytox Solutions In... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/20/2013
Financials
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.21 |
| Annual revenue (last year) | $81.9M |
| Annual profit (last year) | $17.2M |
| Net profit margin | 21.02% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Ronan O'Caoimh |
Chief Operating Officer & Director Rory Nealon |
Corporate headquarters Bray, Wicklow |
Forecasts
